SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

AISAP raises $13 Million in Seed for its AI ultrasound solution

Sam Altman-backed Apex emerges from stealth with $7M to help secure AI adoption

Gigi Levy-Weiss: "Creating jobs is no longer enough to fulfill one’s Zionist duty; we must change the country"

Full list of Israeli high-tech funding rounds in 2024

Buzz

Most popular

Daily

Weekly

1

Wiz deal to acquire Lacework collapses

2

Nvidia to acquire AI startup Deci for $300 million

3

Israeli Billionaire Hires Black Cube to Spy on Former Partner Company Vale

4

Permira acquiring control of BioCatch at $1.3 billion valuation

5

Sam Altman-backed Apex emerges from stealth with $7M to help secure AI adoption

InMode

5 stories about InMode

משה מזרחי מייסד חברת הום סקינוביישנס

Medical Aesthetic Company InMode in Talks for Secondary Offering

23.12.19|Golan Hazani

The Israel-based company listed on Nasdaq in August at a $450 million company valuation but has since reached a $1.3 billion market capitalization

Dreams of Eternal Youth Boost InMode’s Valuation

04.11.19|Sophie Shulman

The medical aesthetic devices manufacturer doubled its market capitalization since its August IPO on Nasdaq, passing the $1 billion mark this past weekend

משה מזרחי מייסד חברת הום סקינוביישנס

Medical Aesthetic Device Manufacturer InMode Raises $70 Million on Nasdaq IPO

11.08.19|Golan Hazani

InMode priced its shares at $14, the lower end of its previously suggested range, giving the company a pre-money valuation of $378 million

Medical Aesthetic Devices Manufacturer InMode Looking to Raise $75 Million on Nasdaq

In June, Calcalist reported that InMode is looking to list on Nasdaq according to a company valuation of $400 million to $500 million

Medical Aesthetic Devices Manufacturer InMode Gearing Up for Nasdaq IPO

03.06.19|Golan Hazani

InMode develops devices that use radio-frequency energy technology, capable of penetrating subdermal fat